All Chemistry World articles in Archive 2004-2009 – Page 111
-
News
Chernobyl fallout impaired mental development of Swedish infants
Study links radiation exposure with poor school performance
-
News
Chemists claim biological alchemy
Neurodazine turns muscle cells from the sole of a human foot into something akin to stem cells
-
News
Nature captured in a test-tube
Chemists hijack biosynthetic pathways to create complex molecules using only enzymes
-
News
China invests more than $1bn in drug safety
Government agencies tackle growing 'fake drugs' problem
-
News
Cheerful news for antidepressant research
Two groups independently solve inhibitor binding conundrum of neurotransmitter carrier
-
News
Molecular heatwave spreads at ferocious pace
Scientists watch heat speed along a hydrocarbon chain
-
News
Structure-recognition software unveiled
Chemists saved the trouble of converting old pictures of chemical structures into computer-readable format
-
News
The burning issue
Fossil fuel combustion in pure oxygen would make greenhouse gasses easier to capture
-
News
Case dismissed on Indian patent law
Claim against government's 'unconstitutional' patent law is dismissed
-
News
Unique antibiotic beats superbugs' resistance
Study shows molecule's antibiotic mechanism and paves way for new group of drugs.
-
News
Making light work of drug release
Photolabile masking agents from organic synthesis used for precision drug delivery.
-
News
Bad milk leads to bald mice
Crucial hormone implicated in alopecia, inflammation, and diabetes.
-
News
Europe poised for a surge in generic drugs
First generic drug to seek pan-European approval gets the go-ahead.
-
News
Now you stick me, now you don't
A new type of reversible adhesion changes stickiness at the flip of a pH switch
-
Podcast
August 2007
Chemistry World Podcast - August 2007(Promo)Brought to you by the Royal Society of Chemistry: The Chemistry World Pod cast.(Promo ends)Interviewer - Chris SmithHello! Welcome to the August edition of the Chemistry World podcast with Chemistry World's editor Mark Peplow and science correspondent, Victoria Gill, Richard Van Noorden, and James Mitchell ...
-
News
FDA advised: Avandia should stay on the market
FDA Advisory Committee votes 22-1 for GSK's diabetes drug to continue to be marketed in the US